SOLV

Solventum Corp

US StockNYSESurgical & Medical Instruments & Apparatus

Research the business. Follow the filings.

Financial information from SEC disclosures, with reporting periods kept in context.

Revenue

8.3B USDAnnual · FY 2025

Operating income

2.2B USDAnnual · FY 2025

Net income

1.6B USDAnnual · FY 2025

Total assets

14.3B USDAnnual · FY 2025

Equity

5B USDAnnual · FY 2025

Operating cash flow

369M USDAnnual · FY 2025

SOLV · Chart

Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.

Reported financial information

Revenue

USD

8.3B USD

Period data
PeriodValue
2022-12-318.1B USD
2023-12-318.2B USD
FY 20248.3B USD
FY 20258.3B USD

Operating income

USD

2.2B USD

Period data
PeriodValue
2022-12-311.7B USD
2023-12-311.7B USD
FY 20241B USD
FY 20252.2B USD

Net income

USD

1.6B USD

Period data
PeriodValue
2022-12-311.3B USD
2023-12-311.3B USD
FY 2024479M USD
FY 20251.6B USD

Total assets

USD

14.3B USD

Period data
PeriodValue
2023-12-3113.9B USD
FY 202414.5B USD
FY 202514.3B USD

Equity

USD

5B USD

Period data
PeriodValue
2021-12-3112.1B USD
2022-12-3111.7B USD
2023-12-3111.7B USD
FY 20243B USD
FY 20255B USD

Operating cash flow

USD

369M USD

Period data
PeriodValue
2022-12-311.7B USD
2023-12-311.9B USD
FY 20241.2B USD
FY 2025369M USD

Revenue growth

%

0.9%

Period data
PeriodValue
2022-12-31N/A
2023-12-310.8%
FY 20240.7%
FY 20250.9%

Operating income growth

%

110.5%

Period data
PeriodValue
2022-12-31N/A
2023-12-31-0.1%
FY 2024-38.8%
FY 2025110.5%

Net income growth

%

224.8%

Period data
PeriodValue
2022-12-31N/A
2023-12-310.2%
FY 2024-64.4%
FY 2025224.8%

Operating margin

%

26.2%

Period data
PeriodValue
2022-12-3120.8%
2023-12-3120.6%
FY 202412.6%
FY 202526.2%

Net margin

%

18.7%

Period data
PeriodValue
2022-12-3116.5%
2023-12-3116.4%
FY 20245.8%
FY 202518.7%

Return on assets

%

10.8%

Period data
PeriodValue
2022-12-31N/A
2023-12-31N/A
FY 20243.4%
FY 202510.8%

Debt/Equity

x

1.83x

Period data
PeriodValue
2022-12-31N/A
2023-12-310.2x
FY 20243.89x
FY 20251.83x